HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
72 hedge funds and large institutions have $74.2M invested in HOOKIPA Pharma in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 9 closing their positions.
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
1% more funds holding
Funds holding: 71 → 72 (+1)
0.05% more ownership
Funds ownership: 4.81% → 4.86% (+0.05%)
8% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 24
35% less capital invested
Capital invested by funds: $114M → $74.2M (-$40.3M)
37% less call options, than puts
Call options by funds: $516K | Put options by funds: $825K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.44M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.24M |
| 3 |
Two Sigma Investments
New York
|
+$1.12M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$930K |
| 5 |
Walleye Capital
New York
|
+$747K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$2.47M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$1.65M |
| 3 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
-$1.01M |
| 4 |
Morgan Stanley
New York
|
-$838K |
| 5 |
Millennium Management
New York
|
-$768K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Russell Investments Group
London,
United Kingdom
| – | -$93K | -1,022 | Closed |
|
|
PHK
77
Point72 Hong Kong
Hong Kong
| – | -$15K | -159 | Closed |
|
|
SOW
78
State of Wyoming
Cheyenne,
Wyoming
| – | -$6K | -62 | Closed |
|
|
TFA
79
Toth Financial Advisory
Leesburg,
Virginia
| – | -$1K | -15 | Closed |
|
HOOK Hedge Fund Activity: Q3 2021 in Review
72 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q3 2021, worth a combined $74.2M — down 35% from $114M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new HOOK positions and 9 closed out — a net gain of 1 holder — while 22 added to existing stakes and 24 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $1.44M. The largest seller was HHLR Advisors, exiting entirely with an estimated $2.47M sold.
- 72 institutional investors held HOOKIPA Pharma (HOOK) as of Q3 2021, up from 71 in Q2 2021.
- Funds reported $74.2M of HOOKIPA Pharma stock for Q3 2021, down 35% quarter-over-quarter.
- 10 funds opened new HOOKIPA Pharma positions in Q3 2021 and 9 closed out, a net change of +1 holder.
- The largest HOOKIPA Pharma buyer in Q3 2021 was Fidelity Investments, an estimated $1.44M added.
- The largest HOOKIPA Pharma seller in Q3 2021 was HHLR Advisors, an estimated $2.47M sold.
Based on aggregated 13F filings for Q3 2021.